Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension

Journal of Hypertension

Volumn 24, Issue 2, 2006, Pages 235-242

  Kuznetsova, Tatiana ^a,b   Staessen, Jan A ^a,m   Brand, Eva ^c,d   Cwynar, Marcin ^e   Stolarz, Katarzyna ^e   Thijs, Lutgarde ^a   Tikhonoff, Valérie ^f   Wojciechowska, Wiktoria ^e   Babeanu, Speranta ^g   Brand Herrmann, Stefan Martin ^h   Casiglia, Edoardo ^f   Filipovský, Jan ⁱ   Grodzicki, Tomasz ^e   Nikitin, Yuri ^b   Peleška, Jan ^j   Struijker Boudier, Harry ^k   Bianchi, Giuseppe ^l   Kawecka Jaszcz, Kalina ^e  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Institute of Internal and Preventive Medicine   (Russian Federation)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e JAGIELLONIAN UNIVERSITY   (Poland)

^f UNIVERSITY OF PADOVA   (Italy)

^g San Luca Hospital   (Romania)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j CHARLES UNIVERSITY   (Czech Republic)

^k MAASTRICHT UNIVERSITY   (Netherlands)

^l VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^m UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

Cardiovascular system; Epidemiology; Gene environment interactions; Genetics

Indexed keywords

ADDUCIN; OUABAIN; SODIUM;

BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ECOLOGICAL GENETICS; GENDER; GENETIC ASSOCIATION; GENOTYPE; HEART LEFT VENTRICLE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; LIFESTYLE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SODIUM EXCRETION; SODIUM URINE LEVEL;

EID: 33644801713     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000194115.89356.bd     Document Type: Review

References (49)

1. Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med 1995; 333:1392-1400.
2. Staessen JA, Wang JG, Birkenhäger WH. Outcome beyond blood pressure control? Eur Heart J 2003; 24:504-514.
3. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet 2003; 361:1629-1641.
4. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001 ; 104:545-556.
5. Harrap SB. Where are all the blood-pressure genes? Lancet 2003; 361:2149-2151.
6. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB. Genetic of essential hypertension. Hum Mol Genet 2004; 13:R169-R175.
7. Matsukawa T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol 1997; 59:395-412.
8. +-ATPase: relation to genetic hypertension. Am J Physiol 1999; 277:H1338-H1349.
9. O'Shaughnessy KM, Karet FE. Salt handling and hypertension. J Clin Invest 2004; 113:1075-1081.
10. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988; 78:951-956.
11. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res 2000; 46:269-276.
12. Tripodi G, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, et al. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest 1996; 97:2815-2822.
13. + hemeostasis in rats. J Appl Physiol 1997; 82:1136-1144.
14. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349:1353-1357.
15. Ferrari P, Ferrandi M, Torielli L, Barassi P, Tripodi G, Minotti E, et al. Antihypertensive compounds that modulate the Na-K pump. Ann NY Acad Sci 2003; 986:694-701.
16. Schoner W, Bauer N, Müller-Ehmsen J, Kramer U, Hambarchian N, Schwinger R, et al. Ouabain as a mammalian hormone. Ann NY Acad Sci 2003; 986:678-684.
17. Wang JG, Staessen JA, Messaggio E, Nawrot T, Fagard R, Hamlyn JM, et al. Salt, endogenous ouabain and blood pressure in the general population. J Hypertens 2003; 21:1475-1481.
18. Ferrari P, Ferrandi M, Torielli L, Tripodi G, Melloni P, Bianchi G. PST2238: a new antihypertensive compound that modulates Na+, K+-ATPase and antagonizes the pressor effect of OLF. Cardiovasc Drug Rev 1999; 17:39-57.
19. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 2002; 269:2440-2448.
20. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993; 153:937-942.
21. Kuznetsova T, Staessen JA, Stolarz K, Ryabikov A, Tikhonoff V, Olszanecka A, et al. Relationship of left ventricular mass and the ACE D/I polymorphism varies according to sodium intake. J Hypertens 2004; 22:287-295.
22. Kuznetsova T, Staessen JA, Thijs L, Kunath C, Olszanecka A, Ryabikov A, et al. Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 2004; 110:2644-2650.
23. Kuznetsova T, Staessen JA, Wang JG, Gasowski J, Nikitin Y, Ryabikov A, et al. Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens 2000; 14:447-454.
24. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
25. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, et al. Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996; 27(Pt 2):569-572.
26. Poch E, González D, Giner V, Bragulat E, Coca A, de la Sierra A. Molecular basis for salt sensitivity in human hypertension. Evaluation of the renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001; 38:1204-1209.
27. Schmieder RE, Langenfeld MRW, Friedrich A, Schobel HP, Gatzka CD, Weihprecht H. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation 1996; 94:1304-1309.
28. Duncan AM, Scholey JW, Miller JA. Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001; 10:111-116.
29. 1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension 1996; 28:1076-1080.
30. Hamon M, Amant C, Bauters C, Richard F, Helbecque N, McFadden E, et al. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart 1997; 77:502-505.
31. Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 1998; 11:316-321.
32. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52:415-472.
33. Warnecke C, Willich T, Holzmeister J, Bottari SP, Fleck E, Regitz-Zagrosek V. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements. Biochem J 1999; 340:17-24.
34. Schmieder RE, Erdmann J, Delles C, Jacobi J, Fleck E, Hilgers K, et al. Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol 2001; 37:175-182.
35. Herrmann SM, Nicaud V, Schmidt-Petersen K, Pfeifer J, Erdmann J, McDonagh T, et al. Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. Eur J Heart Failure 2002; 4:707-712.
36. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997; 30:1238-1246.
37. Siragy HM, Inagami T, Ichiki T, Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 1999; 96:6506-6510.
38. Huang Y, Wang DH. Role of AT1 and AT2 receptor subtypes in salt-sensitive hypertension induced by sensory nerve degeneration. J Hypertens 2001; 19:1841-1846.
39. DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 2000; 36:1083-1088.
40. Stolarz K, Staessen JA, Kawecka-Jaszcz K, Brand E, Bianchi G, Kuznetsova T, et al. Genetic variation in CYP11B2 and ATR1 influences heart rate variability conditional on sodium excretion. Hypertension 2004; 44:156-162.
41. Veglio F, Melchio R, Rabbia F, Molino P, Martini G, Chiandussi L. Spectral characteristics of heart rate and blood pressure variability in primary aldosteronism. Am J Hypertens 1995; 8:479-486.
42. Spinelli L, Petretta M, Marciano F, Testa G, Rao MA, Volpe M, et al. Cardiac autonomic responses to volume overload in normal subjects and in patients with dilated cardiomyopathy. Am J Physiol 1999; 277:H1361-H1368.
43. Beretta-Piccoli C, Weidmann P, Brown JJ, Davies DL, Lever AF, Robertson JIS. Body sodium and blood volume state in essential hypertension: abnormal relation of exchangeable sodium to age and blood pressure in male patients. J Cardiovasc Pharmacol 1984; 6(Suppl 1): S134-S142.
44. Strehlow K, Nickenig G, Roeling J, Wassmann S, Zolk O, Knorr A, et al. AT1 receptor regulation in salt-sensitive hypertension. Am J Physiol 1999; 277:H1701-H1707.
45. Wojciechowska W, Staessen JA, Stolarz K, Nawrot T, Filipovsky J, Ticha M, et al. Association of peripheral and central arterial wave reflections with the CYP11B2 -344C allele and sodium excretion. J Hypertens 2004; 22:2311-2319.
46. Takeda Y. Pathophysiological roles of vascular 11 beta-hydroxysteroid dehydrogenase and aldosterone. J Steroid Biochem Mol Biol 2003; 85:443-447.
47. Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, et al. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 2002; 347:2122-2132.
48. Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002; 296:695-698.
49. Hamet P, Pausova Z, Adarichev V, Adaricheva K, Tremblay J. Hypertension: genes and environment. J Hypertens 1998; 16:397-418.